DUX4 is a transcription factor whose misexpression in skeletal muscle causes 26 facioscapulohumeral muscular dystrophy (FSHD). While DUX4's transcriptional activity has been 27 extensively characterized, the DUX4-induced proteome remains undescribed. Here, we report 28 concurrent measurement of RNA and protein levels in DUX4-expressing cells via RNA-seq and 29 quantitative mass spectrometry. DUX4 transcriptional targets were robustly translated, confirming 30 the likely clinical relevance of proposed FSHD biomarkers. However, a multitude of mRNAs and 31 proteins exhibited discordant expression changes upon DUX4 expression. Our dataset revealed 32 unexpected proteomic, but not transcriptomic, dysregulation of diverse molecular pathways, 33
Introduction 40
Facioscapulohumeral muscular dystrophy is caused by the inappropriate expression of an 41 early embryonic transcriptional activator, DUX4, in adult muscle, leading to cell death (1, 2) . 42
Decades of work have generated a detailed parts-list of the genes and pathways affected by 43 DUX4 that may underlie FSHD pathophysiology (3) (4) (5) (6) (7) (8) (9) (10) . Yet, an integrated model for how those 44 DUX4-induced changes lead to disease has remained elusive (11) (12) (13) . Considering that transient 45 and pulsatile expression of DUX4 is sufficient induce pathology and cell death (14), it is particularly 46 important that we understand the cellular events and pathways set in motion by DUX4 that lead 47 to eventual cell death in order to develop effective therapeutics for FSHD. 48 DUX4 induces changes in the expression of hundreds of genes that impact dozens of 49 highly interconnected pathways (3-10), making a cause-effect relationship between the measured 50 gene expression and the observed pathology difficult to discern. Given that DUX4 is a strong 51 transcription factor, most studies on DUX4 activity have focused on measuring gene expression 52 at the transcript-level (3, 14, 15) , making the assumption that the transcriptome is an accurate 53 representation of the cellular proteome in DUX4-expressing cells. While this is a reasonable 54 assumption, it is well known that RNA and protein levels are not always concordant and post-55 transcriptional regulation can cause them to significantly diverge (16) . The few early proteomics 56 studies that exist were conducted on FSHD muscle biopsies and lack the depth necessary to 57 draw meaningful comparisons with the DUX4 transcriptome (17) (18) (19) . Given our recent discovery 58 that DUX4 induces proteolysis of a key RNA binding protein, UPF1 (7), we hypothesized that 59 post-transcriptional gene regulation could be an important factor to consider in understanding 60 DUX4 biology. Hence, we set out to generate reliable protein-level measurements of DUX4-61 induced gene expression and thereby elucidate the extent of post-transcriptional gene regulation 62 in DUX4-expressing cells. 63
Using SILAC-based quantitative mass spectrometry (20), we measured the fold-change 64 at the protein level for ~4000 genes upon DUX4 expression, with high confidence. Comparing the 65 transcript fold-change to the protein fold-change shows three distinct patterns of expression for 66 different subsets of genes: 1) Concordant change in expression at the RNA and protein level for 67 a number of direct DUX4 transcriptional targets; 2) Post-transcriptional buffering of the expression 68 of a large number of genes, especially of those involved in stress response; and 3) Discordant 69 gene expression change at the RNA versus protein level that included genes involved in RNA 70 surveillance. Together, these findings highlight the importance of considering the expressed 71 proteome to fully understand DUX4 biology and the FSHD disease process. 72
Results 73
Determining protein fold-change in DUX4-expressing cells via quantitative mass 74
spectrometry. 75
In order to measure DUX4-induced changes to the cellular proteome, we conducted 76 SILAC-based mass spectrometry in two independent DUX4 expression systems (Figure 1A) . We 77 have previously shown that DUX4 expressed via a lentiviral vector versus an inducible transgene 78 integrated into the genome of a myoblast cell line both yield comparable gene expression profiles 79 (21). Here, we use both of the expression systems to provide a stringent biological replicate for 80 our proteomic analysis. 81
In a pilot-scale proteomics experiment, human muscle cells that were adapted to light or 82 heavy SILAC media for 3 weeks were transduced with lentivirus carrying DUX4 (vDUX4) or GFP 83 (vGFP) expression constructs and samples were collected 24 and 36 hours post-transduction. In 84 an independent experiment, cells carrying a doxycycline-inducible DUX4 transgene (iDUX4; (21)) 85 were adapted to SILAC media for 3 weeks and DUX4 expression was induced with 1µg/ml of 86 doxycycline for 14 hours in two replicates carrying heavy and light SILAC labels. Paired controls 87 with no treatment were also collected with both heavy and light labels. Total protein from cells 88 expressing DUX4 were mixed with an equal amount of total protein from cells without DUX4 89 expression containing the opposite SILAC label to generate samples that were then subjected to 90 mass spectrometry. 91
Peptide-spectrum matches (PSMs) with quantified heavy to light ratios were subject to 92 thorough screening for quality (e.g., filtering out single-peak spectra and spectra without unique 93 mapping; see Materials & Methods for further details; Supplemental Data Set 1). Peptides 94 mapping to a DUX4 target gene, ZSCAN4, from both vDUX4 and iDUX4 datasets showed highly 95 skewed log2 (DUX4/Control) ratio that showed significant upregulation of the proteins upon DUX4 96 expression ( Figure 1B-C) . In contrast, plotting the log2 (DUX4/Control) ratio of all individual 97 peptides mapping to a housekeeping gene RPL15 showed that the ratio is centered around zero 98 ( Figure 1B-C) , as would be expected for a gene with no differential expression upon DUX4 99 induction. These example plots illustrate the strong agreement between the expected and 100 observed protein fold-change values determined by SILAC mass spectrometry. Moreover, out of 101 the 65 genes identified by Yao et al (22) as potential FSHD biomarkers based on transcriptome 102 analysis of FSHD patient samples, 8 were quantified in the vDUX4 proteomics study and 25 were 103 quantified in the iDUX4 proteomics study and both show high induction at the protein level ( Figure  104 1D, E). Note that the lower number of peptides (and hence quantified proteins) from the vDUX4 105 sample indicates the lower depth of this dataset, and yet yields fold-changes that are highly 106 consistent with the iDUX4 dataset with a higher depth. 107 108 Assessing concordance of RNA and protein expression fold-change. 109
Next, using the iDUX4 dataset, we performed peptide to protein summarization via median 110 heavy/light ratios of all the peptides mapping to a certain protein in both replicates to obtain gene-111 level log2 (DUX4/Control) ratios (Figure S1; Supplemental Data Set 2). After filtering out genes 112 that were only observed in one of the two label-swap replicates, we obtained quantitative 113 proteomics information for 4005 genes, 3961 of which also had a corresponding RNA-seq 114 measurement (Figure 2A ; RNA-seq data previously reported in (21)). The lower number of genes 115 quantified via proteomics compared to RNA-seq is expected as proteomics is known to have lower 116 sensitivity compared to To qualitatively compare the RNA and protein expression level changes upon DUX4 118 expression, we assessed the overlap of genes with an expression change of 4-fold or above. 119
Among genes that are upregulated (> 2 log2 fold change), the concordance between RNA and 120 protein was roughly 40-50%, whereas similarly downregulated genes show very little concordance 121 (Figure 2A) . To obtain a more quantitative measure of concordance, we generated a scatter plot 122 of the RNA versus protein fold-change for the 3961 genes ( Figure 2B ). We found a reasonable 123 level of correlation between these values with a Pearson's correlation coefficient, r, of 0.51 (p-124 value < 2.2e-16). 125
To assess whether similar pathways were affected at the RNA versus protein level, we 126 conducted gene ontology analysis for genes up-or down-regulated at the RNA and protein 127 ( Figure 2C) . Surprisingly, we observed that the pathways that are affected at the RNA versus 128 protein levels are quite distinct. While the transcript level changes occur in genes involved in 129 transcription and mRNA processing, protein-level changes impact pathways including humoral 130 immune response, proteolysis and exocytosis. As the exocytosis pathway has not been implicated 131 in any of the previous DUX4 gene expression studies, we sought to examine this phenomenon 132 further by imaging the Golgi apparatus, which is the source of exocytotic vesicles in the cell (23). 133
We found that DUX4 expressing cells showed severe fragmentation of Golgi apparatus, which 134 could be an indicator of a perturbation in the cellular secretory pathways (24) (Figure 2D ; 135 quantified in Figure 2E ). 136
Taken together, these results demonstrate that analyzing the protein measurements may 137
give us insights that are not discernable in the transcriptome fold-change analysis performed in 138 earlier studies. 139 140 Post-transcriptional buffering of stress response genes may exacerbate DUX4 toxicity. 141 Though many of the genes induced at the transcript level are largely also induced at the 142 protein-level, a subset of genes showed no change in their protein level despite their transcripts 143 were up-or down-regulated to a significant degree (678 genes, shaded blue in Figure 3A) , 144 indicating post-transcriptional buffering of the protein levels. Most notably, several housekeeping 145 genes that respond to protein folding stress or dsRNA-induced stress showed transcriptional 146 upregulation with minimal protein-level upregulation (Figure 3B) . 147
Given that both unfolded protein and dsRNA induced stresses converge in 148 phosphorylation of eIF2a and lead to translation inhibition (25), we asked if the timing of 149 transcription of various stress-response genes coincide with translational downregulation. We 150 found that HSPA5, a prominent marker of the unfolded protein response pathway (26) Next, we focused our analysis on the subset of genes that showed significant changes at 159 the protein level with either no change in their transcript abundance or a change in the opposite 160 direction (198 genes shown as 'gold' circles in Figure 4A ). Pathway analysis did not reveal any 161 significant trends among these genes. So instead, we decided to focus on one of the pathways 162 that we have previously shown to be post-transcriptionally modulated -namely, the nonsense-163 mediated RNA decay (NMD) pathway (7). 164
A diagram showing RNA-vs protein-level changes to various components of this pathway 165 demonstrates substantial post-transcriptional regulation in this pathway (Figure 4B ). Many of 166 these genes, including UPF1, UPF2, UPF3B and XRN1, showed downregulation at the protein 167 level. The downregulation of XRN1 is of particular interest as it is the 5'-3' exonuclease that 168 degrades NMD targets upon cleavage by the endonuclease, SMG6 (27). Moreover, SMG6 too is 169 downregulated to a log2 fold change of -4.7, though it is only detected via a single peptide and 170 hence was filtered out of our analysis. Thus, DUX4-induced NMD inhibition appears to be a result 171 of post-transcriptional downregulation of multiple key players of the NMD pathway, which explains 172 the severity of NMD inhibition in DUX4-expressing cells. 173
Post-transcriptional downregulation of a gene can be achieved via two means: reduced 174 translation or increased protein degradation. We have previously shown that DUX4 induces 175 proteasome-mediated degradation of UPF1 (7). Hence, we asked if DUX4 affects known 176 components and regulators of the ubiquitin proteasome. A scatterplot of all ubiquitin proteasome 177 regulators shows a change in the expression of several such genes, one or more of which may 178 underlie the rapid degradation of UPF1 (Figure 4C) . Further studies are needed to understand 179 the precise molecular mechanism behind this regulatory pathway and its downstream 180 consequences. In summary, we propose that the post-transcriptional gene regulation plays a 181 critical role in inhibiting NMD and perturbing the proteostasis in DUX4-expressing cells and may 182 thus underlie key aspects of FSHD pathology (Figure 4D) . 183
Finally, in order to enable researchers and patients in the FSHD community to access the 184 data generated in this study, we developed a web tool for easy visualization of these data 185 (Screenshot shown in Figure S2 ). This tool can be freely accessed at the following URL: Most of the highly induced DUX4 transcriptional targets are germline and early embryonic 192 genes that are normally never expressed in adult muscle (3). So, it is possible that despite being 193 expressed at the transcript level, such genes may be translated poorly and/or be degraded rapidly 194 upon translation due to the lack of cell-type chaperones or other factors. Here, we show using 195 quantitative mass spectrometry that DUX4-induced transcripts are efficiently translated to 196 produce stable proteins in the muscle cell. This is an important confirmation for the altered identity 197 of DUX4-expressing cells, and also provides validation to pursue some of these proteins as 198 potential FSHD biomarkers (22). 199
Next, we asked if the changes in the DUX4 proteome are largely reflective of the changes 200 to the transcriptome. We find that this is not the case. While there is a positive correlation between 201 these measurements (Pearson's correlation coefficient 0.51), hundreds of genes deviate from this 202 trend. GO analysis of the most differentially expressed genes at the transcript versus protein level 203 shows splicing and RNA processing as being the prominent categories impacted at the transcript 204 level while protein-level changes impact an entirely different set of pathways. We take these 205 results as indication that the transcriptome analysis does not paint a complete picture of DUX4 206 biology and needs to be complemented with proteome analysis to develop a more thorough 207 understanding of how DUX4 misexpression causes FSHD. 208
We next pursued the various mechanisms by which protein-level changes deviate from 209 the corresponding transcriptomic changes. We found that genes induced by dsRNA and unfolded 210 protein stress are transcriptionally induced, but translationally buffered as a result of the 211 translation repression that accompanies these stress-response pathways. As a result, we 212 postulate that the DUX4-expressing cells are unable to mount a robust stress response, despite 213 inducing the transcripts necessary to alleviate stress. We also show that multiple proteins in the 214 which may explain the drastic reduction in RNA quality control capacity in DUX4-expressing cells. 216
From the proteomics data, we have identified a number of genes involved in the ubiquitin 217 proteasome pathway that could impact the stability of proteins, which should serve as a starting 218 point for further investigation into this novel regulatory mechanism of RNA surveillance in DUX4-219 expressing cells. 220 containing protein was cut into 16 fractions using a GelCutter (Gel company Inc.). Individual gel 239 slices in 1.5 mL tubes (Eppendorf) were consecutively washed with water and incubated with 240 25mM ammonium bicarbonate, 50% acetonitrile for 2 hrs. The gel pieces were dehydrated with 241 acetonitrile. And the dried gel slices were reduced by covering them with 10 mM dithiothreitol in 242 100 mM ammonium bicarbonate and heating them at 56 o C for 45 min. The solution was removed 243 and discarded. The gel slices were alkylated by covering them with a solution of 50 mM 244 iodoacetamide in 100 mM ammonium bicarbonate and incubating in the dark at ambient temperature for 30 min. The solution was removed and discarded. The gel slices were dehydrated 246 with acetonitrile, then washed with 100 mM ammonium bicarbonate 100 mM for 10 min. The 247 solution was removed, discarded and the gel slices were dehydrated once again with acetonitrile. 248
Materials and Methods
After removing acetonitrile, the gel slices were then hydrated with 5 ng/uL sequencing grade 249 trypsin (Promega) in 50 mM ammonium bicarbonate and digested overnight at 37 o C on an orbital 250 shaker. Following digestion, the supernatants were collected, and the gel slices were washed with 251 0.1% trifluoroacetic acid, and after 30 min an equal volume of acetonitrile was added followed by Chromatographic elution consisted of a 90-minute gradient from 3% to 27% B and the column 279 temperature was maintained at 40℃. The OrbiTrap Fusion was operated in the 2 second "top 280 speed" data dependent acquisition mode with MS survey scans in the OrbiTrap at least every 2 281 seconds (AGC target value 4E5, resolution 120,000, and maximum injection time of 50 ms). 282
Quadrupole isolation was set to 1.6 FWHM and higher energy collision dissociation (HCD) was 283 used for fragmentation at a collision energy of 28% and MS/MS detection was carried out in the 284 linear ion trap set at rapid scan speed (injection time of 250 ms and AGC target of 10E2). 285
Positively charged ions from 2 to 6 were selected for MS/MS and selected ions were dynamically 286 excluded for 30 seconds. 287
288 Data analysis and statistical methods. Qualitative and quantitative data analysis were 289 performed using Proteome Discoverer 2.1 (Thermo Scientific). The data were searched against 290 a human UniProt database (downloaded 11-04-16) that was appended with protein sequences 291 from the common repository of adventitious proteins (cRAP; www.thegpm.org/crap/) an in silico 292 translation products of noncanonical transcript isoforms stabilized due to NMD inhibition. In 293 downstream analyses, peptides that only mapped to NMD targets were not considered any further 294 in the current study and will be pursued in a future investigation. Searches were conducted with 295 the trypsin enzyme specificity. The precursor ion tolerance was set to 10 ppm and the fragment 296 ion tolerance was set to 0.6 Da. Variable modifications were set for oxidation on methionine 297 (+15.995 Da), carbamidomethyl (+57.021 Da) on cysteine, and acetylation (+42.010 Da) on the 298 N-terminus of proteins. Heavy SILAC amino acids for lysine (+8.014 Da) and arginine (10.008) 299
were also accounted for in the analysis as variable modifications. All search results were 300 evaluated by Percolator (29) for false discovery rate (FDR) evaluation of the identified peptides. 301
Peptide identifications were filtered to a peptide FDR of 1%. All downstream data analysis was 302 conducted using the R statistical programming language. The complete code to reproduce the 303 analyses and figures in this manuscript is deposited in github, available at the following URL: 304 https://github.com/sjaganna/2018-jagannathan_et_al. 305 306 Gene Ontology analysis. GO analysis was performed via the Overrepresentation Enrichment 307 Analysis method using WebGestalt server (pmid: 15980575; www.webgestalt.org). One of the 308 GO categories identified as enriched in this analysis was skin development, which we 309 subsequently removed from Figure 2C as many of the genes that contributed to this GO category 310 were extracellular proteins including keratins that could be environmental contaminants. 311 312 Immunofluorescence microscopy. Cells were permeabilized with PBS containing 0.1% Triton 313 X-100 for 5 minutes at room temperature and rinsed thrice in PBS. Primary antibody against 314 GM130 (Bethyl Laboratories, Cat # A303-402A-T) was diluted 1:200 in PBS and incubated for 1 315 hour at room temperature. After three washes in PBS, secondary anti-Rabbit TRITC (Jackson 316
ImmunoResearch, cat # 711-025-152) diluted 1:400 was added and incubated for 45 minutes at 317 room temperature. Cells were washed thrice in PBS with the nuclear counterstain DAPI included 318 in the final wash. Images were collected on a Cytation 5 multimode reader (BioTek) and analyzed 319 using GenPrime software (BioTek). 320 CCNA1  DUXA  HNRNPCL1  KDM4E  KHDC1L  LEUTX  MBD3L3  PRAMEF1  PRAMEF11  PRAMEF12  PRAMEF14  PRAMEF2  PRAMEF6  RFPL2  RFPL4B  SLC34A2  TPRX1  TRIM43  TRIM43B  TRIM49  ZNF705G  ZSCAN4  DUXA  KHDC1L  LEUTX  MBD3L4  PRAMEF12  PRAMEF2  RFPL4B  SLC34A2  TRIM43  TRIM43B 
